MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioMarin Pharmaceutical Company Profile (NASDAQ:BMRN)

Consensus Ratings for BioMarin Pharmaceutical (NASDAQ:BMRN) (?)
Ratings Breakdown: 3 Hold Rating(s), 18 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $147.67 (10.88% upside)

Current Analysts' Coverage Summary for BioMarin Pharmaceutical (NASDAQ:BMRN)
Show:
DateFirmActionRatingPrice TargetActions
8/25/2015Jefferies GroupLower Price TargetBuy$170.00 -> $166.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015WedbushReiterated RatingNeutral$131.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Cowen and CompanyReiterated RatingBuy$175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015RBC CapitalReiterated RatingBuy$145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Deutsche BankReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015William BlairReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Bank of AmericaBoost Price TargetBuy$140.00 -> $165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015NomuraReiterated RatingBuy$163.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015SunTrustReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Piper JaffrayBoost Price TargetOverweight$163.00 -> $168.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Leerink SwannReiterated RatingBuy$143.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015Robert W. BairdReiterated RatingHold$133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Canaccord GenuityBoost Price TargetBuy$115.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015BarclaysBoost Price TargetOverweight$150.00 -> $156.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015JPMorgan Chase & Co.Boost Price TargetOverweight$140.00 -> $151.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Citigroup Inc.Reiterated RatingBuy$94.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Evercore ISIInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2014Goldman SachsUpgradeNeutral -> Buy$78.00 -> $104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014Credit SuisseReiterated RatingOutperform$74.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013HSBCBoost Price TargetOverweight$46.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2013Stifel NicolausDowngradeBuy -> Hold$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha